国际癌症会议期刊 SCIE

期刊简介预计审稿时间：

this Online-only Journal Publishes Original Case Reports On All Types Of Cancer. In Particular, We Welcome Not Only Case Reports Of Educational Value In The Diagnosis And Treatment Of Cancers, But Also Reports On Molecularly Analyzed Cancer Cases, Including Gene Mutations, Gene Fusions, Gene Expression, And Changes In Copy Number, Regardless Of Their Known Clinical Significance. Assessing The Molecular Analysis Of A Tumor Usually Requires A “cancer Conference” In Which Experts From Various Fields Discuss It. Even If The Authors And Their Respective “cancer Conference” Were Unable To Determine The Clinical Significance Of Molecular Changes At The Time Of Submission And Publication, Their Data May Provide Evidence That Will Help The Scientific Community Develop Precision Medicine Solutions In The Future. We Welcome Case Reports With Reviews Of The Literature On Similar Cases, As They Are More Useful And Valuable To Readers Than Are Reports Of Rare Cases. International Cancer Conference Journal Is The Official Publication Of The Japan Society Of Clinical Oncology (jsco).

- Presents An Online-only Collection Of Original Case Reports On All Types Of Cancer

- In Particular, Welcomes Molecularly Analyzed Cancer Cases

- The Official Publication Of The Japan Society Of Clinical Oncology (jsco)

本在线期刊发表所有类型癌症的原创病例报告。特别是，我们不仅欢迎在癌症诊断和治疗方面具有教育价值的病例报告，也欢迎对癌症病例进行分子分析的报告，包括基因突变、基因融合、基因表达和拷贝数变化，无论其已知的临床意义如何。评估肿瘤的分子分析通常需要召开“癌症会议”，各领域的专家会对此进行讨论。即使作者及其各自的“癌症会议”在提交和发表时无法确定分子变化的临床意义，他们的数据也可能提供证据，帮助科学界在未来开发精准医疗解决方案。我们欢迎病例报告和对类似病例的文献评论，因为它们对读者来说比罕见病例报告更有用、更有价值。《国际癌症会议期刊》是日本临床肿瘤学会 (jsco) 的官方出版物。

- 提供所有类型癌症的原始病例报告的在线集合

- 特别欢迎分子分析的癌症病例

- 日本临床肿瘤学会 (jsco) 的官方出版物

如果您需要协助投稿或润稿服务，您可以咨询我们的客服老师。我们专注于期刊投稿服务十年，熟悉发表政策，可为您提供一对一投稿指导，避免您在投稿时频繁碰壁，节省您的宝贵时间，有效提升发表机率，确保SCI检索（检索不了全额退款）。我们视信誉为生命，多方面确保文章安全保密，在任何情况下都不会泄露您的个人信息或稿件内容。